Chronic graft versus host disease of oral mucosa: review of available therapies.

Abstract

The use of hematopoetic stem cell transplantation (HSCT) has greatly expanded in the recent years for many neoplastic and hematological disorders. Chronic graft versus host disease (cGVHD) is a major complication of allogeneic HSCT and a major cause of morbidity and mortality. Oral mucosal involvement is frequent in cGVHD and contributes significantly to the overall burden of the condition. Oral medicine professionals should be familiar with various treatment options for oral cGVHD. This review discusses treatment modalities available for the management of oral mucosal manifestations of cGVHD. Available evidence for efficacy and safety of various systemic and topical agents, including corticosteroids, calcineurin antagonists, mycophenolate mofetil, and extracorporeal photopheresis, is reviewed.

010020020072008200920102011201220132014201520162017
Citations per Year

478 Citations

Semantic Scholar estimates that this publication has 478 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Imanguli2006ChronicGV, title={Chronic graft versus host disease of oral mucosa: review of available therapies.}, author={Matin M Imanguli and Steven Z Pavletic and Jean-Pierre Guadagnini and Jaime S Brahim and Jane C. Atkinson}, journal={Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics}, year={2006}, volume={101 2}, pages={175-83} }